{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:14:24Z","timestamp":1788869664202,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02366-z","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:34:23Z","timestamp":1782272063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between C-reactive protein-triglyceride glucose index combined with anthropometric indices and mortality risk in individuals with cardiovascular-kidney-liver-metabolic syndrome: a national cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yeshen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6457-2484","authenticated-orcid":false,"given":"Zhihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"20","key":"2366_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association. Circulation. 2023;148(20):1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"issue":"2","key":"2366_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/biom15020213","volume":"15","author":"N Theodorakis","year":"2025","unstructured":"Theodorakis N, Nikolaou M. From cardiovascular-kidney-metabolic syndrome to cardiovascular-renal-hepatic-metabolic syndrome: proposing an expanded framework. Biomolecules. 2025;15(2):15. https:\/\/doi.org\/10.3390\/biom15020213.","journal-title":"Biomolecules"},{"issue":"15","key":"2366_CR3","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.jacc.2025.12.015","volume":"87","author":"F Zannad","year":"2026","unstructured":"Zannad F, Khan MS, Bansal N, B\u00f6hm M, Francque SM, Girerd NJanuzzi JL, et al. MASLD, MASH, and the CKM spectrum: a roadmap for multiorgan clinical trial design. JACC. 2026;87(15):2006\u201333. https:\/\/doi.org\/10.1016\/j.jacc.2025.12.015.","journal-title":"JACC"},{"issue":"6","key":"2366_CR4","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/s11427-025-3193-9","volume":"69","author":"XD Zhou","year":"2026","unstructured":"Zhou XD, Fan QY, Targher G, Byrne CD, Chen QF, Shapiro MD, et al. MASLD as a systemic metabolic disease: expanding the scope of cardiovascular-kidney-metabolic (CKM) syndrome. Sci China Life Sci. 2026;69(6):1950\u201365. https:\/\/doi.org\/10.1007\/s11427-025-3193-9.","journal-title":"Sci China Life Sci"},{"key":"2366_CR5","doi-asserted-by":"publisher","first-page":"101405","DOI":"10.1016\/j.ajpc.2025.101405","volume":"25","author":"Y Chen","year":"2026","unstructured":"Chen Y, Himan HR, Yazicioglu Y, Goh R, Chin YH, Chong B, et al. Population estimates, trends, characteristics and prognostic outcomes of cardiovascular-kidney-liver-metabolic health: a population-based study. Am J Preventative Cardiol. 2026;25:101405. https:\/\/doi.org\/10.1016\/j.ajpc.2025.101405.","journal-title":"Am J Preventative Cardiol"},{"issue":"1","key":"2366_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/re9.0000000000000014","volume":"2","author":"Q Wang","year":"2026","unstructured":"Wang Q, Wang T, Wen J, Chang M. Trends in cardiovascular\u2013kidney\u2013metabolic\u2013related mortality among US adults, 1999\u20132023. Card Res. 2026;2(1):65\u201368. https:\/\/doi.org\/10.1097\/re9.0000000000000014.","journal-title":"Card Res"},{"issue":"6","key":"2366_CR7","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2026.02.018","volume":"38","author":"H Tilg","year":"2026","unstructured":"Tilg H, Adolph TE, Romeo S, Loomba R. The many pathways driving liver inflammation in MASH. Cell Metab. 2026;38(6):1054\u201374. https:\/\/doi.org\/10.1016\/j.cmet.2026.02.018.","journal-title":"Cell Metab"},{"issue":"1","key":"2366_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","volume":"24","author":"H Ou","year":"2025","unstructured":"Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0\u20133 of cardiovascular\u2013kidney\u2013metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):296. https:\/\/doi.org\/10.1186\/s12933-025-02848-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2366_CR9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/JS9.0000000000003560","volume":"112","author":"G Song","year":"2026","unstructured":"Song G. The C-reactive protein-triglyceride glucose index (CTI) predicts mortality in cardiovascular-kidney-metabolic syndrome: a dual-cohort study with machine learning validation. Int J Surg. 2026;112(1):1340\u201352. https:\/\/doi.org\/10.1097\/JS9.0000000000003560.","journal-title":"Int J Surg"},{"issue":"1","key":"2366_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-026-03119-x","volume":"25","author":"XF Jin","year":"2026","unstructured":"Jin XF, Su ZJ, Zhong JF, Wang J, Shi BJ, Liu ZY, et al. Association of the C-reactive protein\u2013triglyceride\u2013glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies. Cardiovasc Diabetol. 2026;25(1):25. https:\/\/doi.org\/10.1186\/s12933-026-03119-x.","journal-title":"Cardiovasc Diabetol"},{"key":"2366_CR11","doi-asserted-by":"publisher","unstructured":"Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol-Cell Physiol. 2021;320(3):C375\u2013c391. https:\/\/doi.org\/10.1152\/ajpcell.00379.2020.","DOI":"10.1152\/ajpcell.00379.2020"},{"issue":"7","key":"2366_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/nu16071015","volume":"16","author":"S Dhokte","year":"2024","unstructured":"Dhokte S, Czaja K. Visceral adipose tissue: the hidden culprit for type 2 diabetes. Nutrients. 2024;16(7):16. https:\/\/doi.org\/10.3390\/nu16071015.","journal-title":"Nutrients"},{"issue":"1","key":"2366_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome stages 0\u20133: a prospective cohort study of 282,920 participants in the UK biobank. Cardiovasc Diabetol. 2025;24(1):277. https:\/\/doi.org\/10.1186\/s12933-025-02842-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2366_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24(1):257. https:\/\/doi.org\/10.1186\/s12933-025-02819-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2366_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12933-025-02716-6","volume":"24","author":"Z Song","year":"2025","unstructured":"Song Z, Miao X, Liu S, Hu M, Xie X, Sun Y, et al. Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study. Cardiovasc Diabetol. 2025;24(1):154. https:\/\/doi.org\/10.1186\/s12933-025-02716-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2366_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12933-025-03070-3","volume":"25","author":"D He","year":"2026","unstructured":"He D, Huang Y, Ni X, Bao Z. Prospective associations of triglyceride-glucose related indices with cardiovascular disease and mortality in individuals with metabolic syndrome: evidence from the UK biobank. Cardiovasc Diabetol. 2026;25(1):53. https:\/\/doi.org\/10.1186\/s12933-025-03070-3.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"2366_CR17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1080\/00325481.2025.2610842","volume":"137","author":"\u00c7 Kaya","year":"2025","unstructured":"Kaya \u00c7, Ebik M, Karda\u015f F, G\u00fcrdo\u011fan M, Altay S. Prognostic impact of TyG-BRI index on in-hospital mortality in elderly-octogenarian patients with ST-elevation myocardial infarction. Postgrad Med. 2025;137(8):830\u201338. https:\/\/doi.org\/10.1080\/00325481.2025.2610842.","journal-title":"Postgrad Med"},{"key":"2366_CR18","doi-asserted-by":"publisher","unstructured":"Liao C, Liu L, Bao W, Lai H, Tian R, Zhang S, et al. Joint associations of anthropometric indices and C-reactive protein-triglyceride-glucose index with incident hypertension: a stratified analysis by blood pressure level from the CHARLS, 2011\u20132020. Cardiovasc Diabetol. 2026;25(1). https:\/\/doi.org\/10.1186\/s12933-026-03132-0.","DOI":"10.1186\/s12933-026-03132-0"},{"issue":"1","key":"2366_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12872-025-05342-y","volume":"25","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li Y, Long X, Li Y, Li Z, Tu S, et al. Combined influence of nutritional and inflammatory status on mortality in cancer survivors complicated with cardiovascular disease. BMC Cardiovasc Disord. 2025;25(1):862. https:\/\/doi.org\/10.1186\/s12872-025-05342-y.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"2366_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y(, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2366_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.32614\/RJ-2019-028","volume":"11","author":"M Quartagno","year":"2019","unstructured":"Quartagno M, Grund S, Carpenter J. Jomo: a flexible package for two-level joint modelling multiple imputation. 2020. R J. 2019;11(2):205. https:\/\/doi.org\/10.32614\/RJ-2019-028.","journal-title":"R J"},{"issue":"12","key":"2366_CR22","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","volume":"324","author":"P Muntner","year":"2020","unstructured":"Muntner P, Hardy ST, Fine LJ, Jaeger BC, Wozniak G, Levitan EB, et al. Trends in blood pressure control among US adults with hypertension, 1999\u20132000 to 2017-2018. JAMA. 2020;324(12):1190\u2013200. https:\/\/doi.org\/10.1001\/jama.2020.14545.","journal-title":"JAMA"},{"issue":"1","key":"2366_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-026-03084-5","volume":"25","author":"SS Han","year":"2026","unstructured":"Han SS, Liu Q, Zeng ZM, Li Y, Li PW, Cheng FX, et al. Association of various insulin resistance surrogate indices with aging acceleration and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133: insights from CHARLS 2011\u20132020 data. Cardiovasc Diabetol. 2026;25(1):25. https:\/\/doi.org\/10.1186\/s12933-026-03084-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2366_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12933-026-03077-4","volume":"25","author":"T Jin","year":"2026","unstructured":"Jin T, Tang X, Han Y, Fan H, Qin Q, Jiang H, et al. Relationship between nine triglyceride-glucose-related indices and cardiometabolic multimorbidity incidence in patients with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026;25(1):36. https:\/\/doi.org\/10.1186\/s12933-026-03077-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2366_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12933-025-02932-0","volume":"24","author":"H Wu","year":"2025","unstructured":"Wu H, Zhou Y, Lai X, Ma B, Ding L, Zhu X, et al. Association between metabolic score for insulin resistance and future stroke risk in patients with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):379. https:\/\/doi.org\/10.1186\/s12933-025-02932-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2366_CR26","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004.","journal-title":"Hepatology"},{"issue":"10","key":"2366_CR27","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/01635581.2023.2273577","volume":"75","author":"DF Zhao","year":"2023","unstructured":"Zhao DF. Value of C-reactive protein-triglyceride glucose index in predicting cancer mortality in the general population: results from national health and nutrition examination survey. Nutr Cancer. 2023;75(10):1934\u201344. https:\/\/doi.org\/10.1080\/01635581.2023.2273577.","journal-title":"Nutr Cancer"},{"key":"2366_CR28","doi-asserted-by":"publisher","first-page":"905266","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"GT Ruan","year":"2022","unstructured":"Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol. 2022;13:905266. https:\/\/doi.org\/10.3389\/fendo.2022.905266.","journal-title":"Front. Endocrinol"},{"issue":"1","key":"2366_CR29","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","volume":"24","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li S, Liu D, Gui J, Hu J, Wang Q, et al. The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24(1):410. https:\/\/doi.org\/10.1186\/s12933-025-02960-w.","journal-title":"Cardiovasc Diabetol"},{"key":"2366_CR30","doi-asserted-by":"crossref","unstructured":"Ye Z, Xie E, Song C, Zhang R, Wang H, Wu C, et al. Prognostic stratification with composite insulin resistance-inflammation biomarkers in patients with chronic kidney disease and coronary artery disease across glycemic statuses. Cardiovasc Diabetol. 2026;25.","DOI":"10.1186\/s12933-026-03108-0"},{"key":"2366_CR31","doi-asserted-by":"publisher","unstructured":"Ni G, Chen Z, Zhu A, Cheang I, Zhu X, Fu Y, et al. Association between C-reactive protein-triglyceride glucose index (CTI) and cardiovascular and all-cause mortality risk among the elderly population: insights from three datasets. Clin Res Cardiol. 2026. https:\/\/doi.org\/10.1007\/s00392-025-02830-1.","DOI":"10.1007\/s00392-025-02830-1"},{"issue":"1","key":"2366_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12872-025-05460-7","volume":"26","author":"\u00c7 Kaya","year":"2026","unstructured":"Kaya \u00c7, \u00d6zt\u00fcrk C. Prognostic value of the CRP\u2013TyG index for in-hospital and 1-year mortality in patients with decompensated heart failure. BMC Cardiovasc Disord. 2026;26(1):65. https:\/\/doi.org\/10.1186\/s12872-025-05460-7.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"2366_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12902-024-01763-6","volume":"24","author":"M Fahami","year":"2024","unstructured":"Fahami M, Hojati A, Farhangi MA. Body shape index (ABSI), body roundness index (BRI) and risk factors of metabolic syndrome among overweight and obese adults: a cross-sectional study. BMC Endocr Disord. 2024;24(1):230. https:\/\/doi.org\/10.1186\/s12902-024-01763-6.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2366_CR34","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1186\/s12889-023-16621-8","volume":"23","author":"J Ye","year":"2023","unstructured":"Ye J, Hu Y, Chen X, Yin Z, Yuan X, Huang L, et al. Association between the weight-adjusted waist index and stroke: a cross-sectional study. BMC Public Health. 2023;23(1):1689. https:\/\/doi.org\/10.1186\/s12889-023-16621-8.","journal-title":"BMC Public Health"},{"key":"2366_CR35","doi-asserted-by":"publisher","unstructured":"Yang M, Liu J, Shen Q, Chen H, Liu Y, Wang N, et al. Body roundness index trajectories and the incidence of cardiovascular disease: evidence from the China health and retirement longitudinal study. JAHA. 2024;13(19):e034768. https:\/\/doi.org\/10.1161\/JAHA.124.034768.","DOI":"10.1161\/JAHA.124.034768"},{"key":"2366_CR36","doi-asserted-by":"publisher","unstructured":"Swainson MG, Batterham AM, Tsakirides C, Rutherford ZH, Hind K. Prediction of whole-body fat percentage and visceral adipose tissue mass from five anthropometric variables. PLoS One. 2017;12(5):e0177175. https:\/\/doi.org\/10.1371\/journal.pone.0177175.","DOI":"10.1371\/journal.pone.0177175"},{"issue":"6","key":"2366_CR37","doi-asserted-by":"publisher","first-page":"104609","DOI":"10.1016\/j.numecd.2026.104609","volume":"36","author":"Y Wang","year":"2026","unstructured":"Wang Y, Luo J, Tan Z, Bai G, Qu X, Shao X, et al. Interactive and joint associations of C-reactive protein-triglyceride glucose index and body roundness index on incident cardiovascular diseases: a nationwide prospective cohort study. Nutr Metab Cardiovasc Dis. 2026;36(6):104609. https:\/\/doi.org\/10.1016\/j.numecd.2026.104609.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"2366_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12933-025-03065-0","volume":"25","author":"Z Zhou","year":"2026","unstructured":"Zhou Z, Yang J, Hou J, Zhang L. The predictive value of C-reactive protein-triglycerides-glucose index-waist-to-height ratio for stroke: a nationwide cohort study. Cardiovasc Diabetol. 2026;25(1):18. https:\/\/doi.org\/10.1186\/s12933-025-03065-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2366_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12933-026-03112-4","volume":"25","author":"G Yang","year":"2026","unstructured":"Yang G, He W, Qiu X, Shen S, Li P, Feng Y, et al. Triglyceride glucose index\u2014a body shape index (TyG-ABSI) outperforms traditional obesity indices in predicting all-cause and cardiovascular mortality in metabolic-dysfunction associated steatotic liver disease: the mediating role of biological aging. Cardiovasc Diabetol. 2026;25(1):25. https:\/\/doi.org\/10.1186\/s12933-026-03112-4.","journal-title":"Cardiovasc Diabetol"},{"key":"2366_CR40","doi-asserted-by":"publisher","unstructured":"Liu H, Guo F, Fu H, Xu X, Wang Z, Kang J, et al. Associations of triglyceride\u2013glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis. Cardiovasc Diabetol. 2026;25(1). https:\/\/doi.org\/10.1186\/s12933-026-03148-6.","DOI":"10.1186\/s12933-026-03148-6"},{"key":"2366_CR41","unstructured":"GBD. Adult BMI collaborators. Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the global burden of disease study 2021. Lancet. 2025. 2021;405:813\u201338."},{"issue":"7121","key":"2366_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"JP Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881\u201387. https:\/\/doi.org\/10.1038\/nature05488.","journal-title":"Nature"},{"issue":"5","key":"2366_CR43","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852\u201371. https:\/\/doi.org\/10.1016\/j.cell.2012.02.017.","journal-title":"Cell"},{"issue":"13","key":"2366_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jcm11133649","volume":"11","author":"R Palma","year":"2022","unstructured":"Palma R, Pronio A, Romeo M, Scognamiglio F, Ventriglia L, Ormando VM, et al. The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications. JCM. 2022;11(13):11. https:\/\/doi.org\/10.3390\/jcm11133649.","journal-title":"JCM"},{"issue":"2","key":"2366_CR45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","volume":"7","author":"D Santoleri","year":"2019","unstructured":"Santoleri D, Titchenell PM. Resolving the paradox of hepatic insulin resistance. Cellular Mol Gastroenterol Hepatol. 2019;7(2):447\u201356. https:\/\/doi.org\/10.1016\/j.jcmgh.2018.10.016.","journal-title":"Cellular Mol Gastroenterol Hepatol"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02366-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02366-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02366-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:03:17Z","timestamp":1788868997000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02366-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2366"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02366-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The NHANES project was approved by the Ethics Review Board of the National Center for Health Statistics, and written informed consent had already been received from each participant. The present study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"260"}}